Works matching IS 11732563 AND DT 2015 AND VI 35 AND IP 8

Results: 8

Pharmacokinetics, Safety and Bioequivalence of Levetiracetam Intravenous Infusion and Oral Tablets in Healthy Chinese Subjects.

Published in:

Clinical Drug Investigation, 2015, v. 35, n. 8, p. 495, doi. 10.1007/s40261-015-0303-9

By:

Toublanc, Nathalie;
Du, Xinlu;
Liu, Yun;
Chen, Qian;
Singh, Pritibha;
Chan, Robert;
Stockis, Armel

Publication type:

Article

Comparing Gabapentin with Clonazepam for Residual Sleeping Problems following Antidepressant Therapy in Patients with Major Depressive Disorder: A Randomized Clinical Trial.

Published in:

Clinical Drug Investigation, 2015, v. 35, n. 8, p. 513, doi. 10.1007/s40261-015-0304-8

By:

Mowla, Arash;
Ahmadzadeh, Laaya;
Razeghian Jahromi, Leila;
Dastgheib, Seyed

Publication type:

Article

Fidaxomicin Pharmacokinetics in Humans: Is There a Role of Biliary Excretion?

Published in:

Clinical Drug Investigation, 2015, v. 35, n. 8, p. 531, doi. 10.1007/s40261-015-0305-7

By:

Srinivas, Nuggehally

Publication type:

Article

Intravesical Glycosaminoglycan Replacement with Chondroitin Sulphate (Gepan instill) in Patients with Chronic Radiotherapy- or Chemotherapy-Associated Cystitis.

Published in:

Clinical Drug Investigation, 2015, v. 35, n. 8, p. 505, doi. 10.1007/s40261-015-0306-6

By:

Schwalenberg, Thilo;
Berger, Frank;
Horn, Lars;
Thi, Phuc;
Stolzenburg, Jens-Uwe;
Neuhaus, Jochen

Publication type:

Article

Raplixa™: A Review in Improving Surgical Haemostasis.

Published in:

Clinical Drug Investigation, 2015, v. 35, n. 8, p. 519, doi. 10.1007/s40261-015-0307-5

By:

McKeage, Kate

Publication type:

Article

Extending the Human Papillomavirus Vaccination Programme to Include Males in High-Income Countries: A Systematic Review of the Cost-Effectiveness Studies.

Published in:

Clinical Drug Investigation, 2015, v. 35, n. 8, p. 471, doi. 10.1007/s40261-015-0308-4

By:

Ben Hadj Yahia, Mohamed-Béchir;
Jouin-Bortolotti, Anaïs;
Dervaux, Benoît

Publication type:

Article

Bromfenac Ophthalmic Solution 0.07 %: A Review of Its Use After Cataract Surgery.

Published in:

Clinical Drug Investigation, 2015, v. 35, n. 8, p. 525, doi. 10.1007/s40261-015-0309-3

By:

Hoy, Sheridan

Publication type:

Article

Safety Profile and Costs of Related Adverse Events of Trastuzumab Emtansine for the Treatment of HER2-Positive Locally Advanced or Metastatic Breast Cancer Compared to Capecitabine Plus Lapatinib from the Perspective of the Canadian Health-Care System.

Published in:

Clinical Drug Investigation, 2015, v. 35, n. 8, p. 487, doi. 10.1007/s40261-015-0302-x

By:

Piwko, Charles;
Prady, Catherine;
Yunger, Simon;
Pollex, Erika;
Moser, Aurelie

Publication type:

Article